2020201920182017201620152014 December 17, 2020 Summary ToggleSpero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer December 16, 2020 Summary ToggleSpero Therapeutics Added to the NASDAQ Biotechnology Index December 10, 2020 Summary ToggleSpero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease December 02, 2020 Summary ToggleSpero Therapeutics Announces Appointment of Tamara Joseph as Chief Legal Officer November 30, 2020 Summary ToggleSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 30, 2020 Summary ToggleSpero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020 November 05, 2020 Summary ToggleSpero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update November 03, 2020 Summary ToggleSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 29, 2020 Summary ToggleSpero Therapeutics to Provide Business Update and Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 October 16, 2020 Summary ToggleSpero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020 Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
